| Literature DB >> 27750392 |
Maria Lennerås1,2, Georgios Tsikandylakis2,3, Margarita Trobos1,2, Omar Omar1,2, Forugh Vazirisani1,2, Anders Palmquist1,2, Örjan Berlin2,3,4, Rickard Brånemark2,3,4,5, Peter Thomsen1,2.
Abstract
The breach of the skin barrier is a critical issue associated with the treatment of individuals with transfemoral amputation (TFA) using osseointegrated, percutaneous titanium implants. Thirty TFA patients scheduled for abutment exchange or removal were consecutively enrolled. The aims were to determine the macroscopic skin signs, the presence of bacteria and the gene expression in abutment-adherent cells and to conduct correlative and comparative analyses between the different parameters. Redness and a granulation ring were present in 47% of the patients. Bacteria were detected in 27/30 patients, commonly in the bone canal. Staphylococcus aureus, coagulase-negative staphylococci, streptococci, and Enterococcus faecalis were the most common. A positive correlation was found between TNF-α expression and the detection of S. aureus. Staphylococcus aureus together with other bacterial species revealed a positive relationship with MMP-8 expression. A negative correlation was demonstrated between the length of the residual femur bone and the detection of a granulation ring and E. faecalis. A positive correlation was revealed between fixture loosening and pain and the radiological detection of endosteal bone resorption. Fixture loosening was also correlated with the reduced expression of interleukin-10 and osteocalcin. It is concluded that several relationships exist between clinical, radiological, microbiological, and molecular assessments of the percutaneous area of TFAs. Further long term studies on larger patient cohorts are required to determine the precise cause-effect relationships and unravel the role of host-bacteria interactions in the skin, bone canal and on the abutment for the longevity of percutaneous implants as treatment of TFA.Entities:
Keywords: gene expression; infection; osseointegration; percutaneous; transfemoral amputees
Mesh:
Substances:
Year: 2016 PMID: 27750392 PMCID: PMC5216444 DOI: 10.1002/jbm.a.35935
Source DB: PubMed Journal: J Biomed Mater Res A ISSN: 1549-3296 Impact factor: 4.396
Figure 1An overview of the implant components, the sampling procedures and the clinical assessment of the skin. (A, B) Schematic drawing showing the implant components and surrounding tissue. Abutments with a diameter of 11 mm and a length of 72–77 mm were machined from cp‐Ti grade IV (n = 29) and titanium alloy (Ti6Al4V, grade V) (n = 1), cleaned by ultrasonication followed by sterilisation. (C‐E) Bacterial swabs taken from skin‐penetration site (C), abutment (D) and bone canal (E). (F, G) Retrieval of abutment for macroscopic inspection (F) and placement in a fixed volume of RNAlater (G) for subsequent RNA and protein extraction. (H‐K) Representative skin‐penetration sites for the scoring system: H) Score 0: clean, dry, tight; I) Score 2: purple, serous secretion; J) Score 3: granulation ring, redness; K) Score 4: granulation ring, redness, serous secretion.
Demographic Data on 30 Patients with TFA and Osseointegrated Bone‐Anchored Amputation Prostheses Undergoing Exchange or Removal of Their Abutments
| Variable | Population | Mean (SD) | Median (min; max) |
|---|---|---|---|
| Patients | 30 | ||
| Unilateral | 28 | ||
| Bilateral | 2 | ||
| Gender (male/female) | 24/6 | ||
| Age at abutment exchange (years) | 51 (13) | 53 (25; 76) | |
| Time since first surgery (S1) (years) | 6.6 (3.8) | 5 (0.6; 16) | |
| Time since last exchange of abutment (years) | 4.4 (3.1) | 3 (2; 13) | |
| Estimated weight at inclusion (S1) (kg) | 77 (18) | 76 (48; 116) |
Modified Holgers Scoring System With Values Ranging From 0 to 6 Depending on the Appearance of the Skin‐Penetration Site (SPS)
| Inspection | ||
|---|---|---|
| Skin color | Normal | 0 |
| Purple | 1 | |
| Red | 2 | |
| Moistness/secretion | No | 0 |
| Serous | 1 | |
| Purulent | 2 | |
| Granulation | No | 0 |
| Yes | 1 | |
| Fistulas | No | 0 |
| Yes | 1 | |
| Sum 0 ‐ 6 |
Figure 2Radiological changes (A‐F). (A) The early (after 3 years) postoperative X‐ray from patient 1 (P1). (B) The corresponding X‐ray at the 10‐year post‐operative follow‐up of P1. Proximal trabecular buttressing (an increase of the bone density at the proximal end of the fixture) (thick, black arrow) and cancellisation (an increase in the porosity of the cortex surrounding the fixture) (thin, black arrow) have developed. (C) The early postoperative X‐ray (after the first surgery, S1) from patient 2 (P2). (D) At two‐years, a cortical thinning (a decrease in the width of the cortex around the fixture) (white arrow‐head) is evident. (E) An early postoperative X‐ray from patient 3 (P3) after the second surgery, S2. (F). The X‐ray from patient 3 after seven years, demonstrates endosteal bone resorption (thin, white arrow) and distal bone resorption (thick, white arrow). Endosteal bone resorption is the resorption of endosteal bone around the threads of the fixture, while distal bone resorption is the resorption of the bone at the distal end of the fixture.
Clinical Signs of the Skin‐Penetration Site (SPS) and Their Frequency
| Clinical sign | No of patients (Frequency) | Percentage (%) |
|---|---|---|
| Normal skin color | 7 | 23 |
| Purpleness | 9 | 30 |
| Redness | 14 | 47 |
| Serous secretion | 5 | 17 |
| Purulent secretion | 3 | 10 |
| Granulation ring | 14 | 47 |
| Fistulas | 0 | 0 |
*n = 30.
Modified Holgers Score
| Modified Holgers score | No of patients |
|---|---|
| 0 | 4 |
| 1 | 7 |
| 2 | 9 |
| 3 | 5 |
| 4 | 3 |
| 5 | 2 |
| 6 | 0 |
| Total | 30 |
Radiological Changes
| Radiological changes since S2 | No of patients (Frequency) | Percentage (%) |
|---|---|---|
| Unchanged | 10 | 33 |
| Endosteal bone resorption | 10 | 33 |
| Distal bone resorption | 0 | 0 |
| Cancellisation | 2 | 7 |
| Cortical thinning | 1 | 3 |
| Proximal trabecular buttressing | 14 | 47 |
*n = 30.
Bacterial Species Found Post Chlorhexidine Exposure at the Skin‐Penetration Site (SPS), Abutment and Bone Canal of Patients (n = 30)
| Bacteria | Number of patients (%) | SPS | Abutment | Bone canal |
|---|---|---|---|---|
|
| 14 (47%) | 7 | 5 | 13 |
| Coagulase‐negative staphylococci (CoNS) | 3 (10%) | 0 | 1 | 3 |
|
| 2 (7%) | 0 | 0 | 2 |
| Group B | 4 (13%) | 1 | 1 | 4 |
| Group G | 1 (3%) | 0 | 1 | 1 |
| Group A | 1 (3%) | 1 | 0 | 1 |
| Alpha‐haemolytic streptococci | 1 (3%) | 0 | 0 | 1 |
|
| 6 (20%) | 0 | 0 | 6 |
|
| 1 (3%) | 0 | 1 | 1 |
|
| 1 (3%) | 1 | 1 | 1 |
|
| 1 (3%) | 0 | 0 | 1 |
|
| 1 (3%) | 0 | 0 | 1 |
|
| 1 (3%) | 0 | 0 | 1 |
|
| 1 (3%) | 0 | 0 | 1 |
| Anaerobic mixed flora | 2 (7%) | 0 | 0 | 2 |
| Gram‐positive skin flora | 2 (7%) | 1 | 1 | 1 |
| No growth | 3 (10%) | 0 | 0 | 0 |
| Total number of positive cultures | 11 | 11 | 40 |
*Several patients displayed the growth of ≥ 2 bacterial species at the same site. #Several patients displayed the growth of bacteria in more than one compartment.
Figure 3Western blot analysis of protein A on the abutment. Examples of positive and negative Staphylococcus aureus protein A detection on abutment. P1: One patient of two who did not demonstrate positive detection of protein A. P2‐P4: Four patients (P2‐P4) with positive bands of Staphylococcus aureus protein A (≈50 kDa) detected in 28/30 patients.
Correlation Analysis of Genes Expressed in the Abutment‐Adherent Cells
| Positive correlations | Negative correlations | ||||
|---|---|---|---|---|---|
| Genes | ( | ( | Genes | ( | ( |
| TNF‐α/IL‐1β | 0.85 | <0.01 | TNF‐α/OPN | −0.426 | <0.05 |
| TNF‐α/IL‐6 | 0.731 | <0.01 | IL‐1β/OPN | −0.46 | <0.05 |
| TNF‐α/TIMP‐1 | 0.487 | <0.01 | IL‐1β/Coll1a1 | −0.39 | <0.05 |
| TNF‐α/ELA‐2 | 0.365 | <0.05 | IL‐1β/Coll4a1 | −0.378 | <0.05 |
| IL‐1β/IL‐6 | 0.721 | <0.01 | IL‐1β/CatK | −0.547 | <0.01 |
| IL‐1β/TIMP‐1 | 0.543 | <0.01 | |||
| IL‐6/Runx2 | 0.452 | <0.05 | |||
| IL‐6/TIMP‐1 | 0.467 | <0.01 | |||
| IL‐6/ELA2 | 0.446 | <0.05 | |||
| Coll1a1/Runx2 | 0.438 | <0.05 | |||
| Coll1a1/Coll4a1 | 0.777 | <0.01 | |||
| Coll1a1/CatK | 0.501 | <0.01 | |||
| OPN/CatK | 0.634 | <0.01 | |||
| OPN/MMP8 | 0.492 | <0.01 | |||
| Runx2/KRT6A | 0.369 | <0.05 | |||
| Runx2/ELA2 | 0.474 | <0.01 | |||
| CatK/Coll4a1 | 0.411 | <0.05 | |||
| CatK/MMP8 | 0.622 | <0.01 | |||
| IL‐10/ELA2 | 0.568 | <0.01 | |||
The data show genes that revealed significant positive or negative relationships. Spearman correlation coefficients (r) and level of significance (p) are presented.
Correlation Analysis Between Clinical Parametersa and Genes Expressed in the Abutment‐Adherent Cells
| Clinical Parameters | Correlated Genes | ( | ( |
|---|---|---|---|
| Time since S1 surgery (fixture installation) | OPN | −0.413 | <0.05 |
| Coll4a1 | −0.378 | <0.05 | |
| Time since last abutment installation | Coll4a1 | −0.521 | <0.01 |
| Fixture loosening | OC | −0.430 | <0.05 |
| IL‐10 | −0.404 | <0.05 | |
| Length of residual femur bone | OC | −0.398 | <0.05 |
No significant correlations were detected for other clinical parameters with any of the analyzed genes.
The data show genes that revealed significant correlations with clinical parameters. Spearman correlation coefficients (r) and level of significance (p) are presented.
Correlation Analysis of Clinical Parametersa
| Positive correlations | Negative correlations | ||||
|---|---|---|---|---|---|
| ( | ( | ( | ( | ||
| Fixture loosening/Endosteal bone resorption | 0.471 | <0.01 | Time since S1 surgery (fixture installation)/Fixture loosening | −0.392 | <0.05 |
| Fixture loosening/Pain symptom | 0.438 | <0.05 | Time since S1 surgery/Pain symptom | −0.412 | <0.05 |
| Skin color/Pain symptom | 0.392 | <0.05 | Length of residual femur bone/Granulation ring | −0.479 | <0.01 |
No significant correlations were detected for the other clinical parameters.
The data show clinical parameters that revealed significant positive or negative relationships. Spearman correlation coefficients (r) and level of significance (p) are presented.
Correlation of Bacterial and Clinical Parametersa
| Bacterial findings | Correlated clinical parameters | ( | ( |
|---|---|---|---|
| Detection of any bacterial species at SPS | Time since last abutment installation | 0.467 | <0.01 |
| Secretion | 0.428 | <0.05 | |
| Detection of any bacterial species on the abutment | Length of residual femur bone | 0.399 | <0.05 |
| Detection of any bacterial species in the bone canal | Time since S1 surgery (fixture installation) | 0.431 | <0.05 |
| Detection of | Length of residual femur bone | −0.398 | <0.05 |
| Detection of | Granulation ring | 0.367 | <0.05 |
No significant correlations were detected for other clinical parameters with any of the analysed bacterial findings.
The data show clinical parameters that revealed significant correlations with bacterial findings. Spearman correlation coefficients (r) and level of significance (p) are presented.
Correlation of Bacteria and Genesa Expressed in the Abutment‐Adherent Cells
| Bacterial findings | Correlated genes | (r) | (p) |
|---|---|---|---|
| Detection of | TNF‐α | 0.394 | <0.05 |
| Detection of coagulase‐negative staphylococci irrespective of site | OPN | 0.392 | <0.05 |
| Detection of | MMP‐8 | 0.531 | <0.01 |
| Detection of polymicrobial flora | Runx2 | 0.400 | <0.05 |
| IL‐6 | 0.423 | <0.05 | |
| MMP‐8 | 0.369 | <0.05 |
No significant correlations were detected for other genes with any of the analyzed bacterial findings..
The data show genes that revealed significant correlations with bacterial findings. Spearman correlation coefficients (r) and level of significance (p) are presented.
Figure 4Gene expression of (A) osteocalcin (OC) and (B) interleukin‐10 (IL‐10) in the abutment‐adherent cells. The comparison was performed between patients with osseointegrated fixtures (n = 27) and patients with loosened fixtures (n = 3). Bars indicate statistically significant differences (p < 0.05).
Figure 5Gene expression of tumour necrosis factor‐alpha (TNF‐α) and matrix metalloproteinase‐8 (MMP‐8) in the abutment‐adherent cells. The comparative analyses were performed as following: (A) TNF‐α expression in patients in whom S. aureus was not detected (n = 16) versus patients in whom S. aureus was detected (n = 14); (B) TNF‐α expression in patients in whom S. aureus was not detected (n = 16) versus patients in whom S. aureus was detected alone (n = 6) or detected with other bacteria (n = 8); (C) MMP‐8 expression in patients in whom S. aureus was not detected (n = 16) versus patients in whom S. aureus was detected alone (n = 6) or detected with other bacteria (n = 8). The bars indicate statistically significant differences (p < 0.05).